Acceptance of Telemedicine During the COVID-19 Pandemic


Currently, due to the effects of COVID-19 pandemic, there is an imperative need to change the healthcare model. In this regard, telemedicine has proved very useful in health crises, in which there is a possibility of infection between people, offering remote access to medical care. Telemedicine has been used in many chronic diseases such as asthma and chronic obstructive pulmonary disease, diabetes mellitus, and appears to be well accepted by patients. However, few studies have been conducted in surgical services and in other diseases. Therefore, the aim of this study is to assess the level of acceptance of the patients, in this pandemic situation, to a telemedicine follow-up in different departments. This is an observational, cross-sectional, multicenter and international study with prospective and retrospective data collection. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ). In addition, all patients will provide an overall satisfaction score for telemedicine on a scale from 1 to 5 (1=lowest; 5=highest satisfaction).

Full Title of Study: “Acceptance of Telemedicine in Outpatient Clinic Consultations During COVID-19 Pandemic. An International, Cross-sectional Study”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 31, 2020

Clinical Trial Outcome Measures

Primary Measures

  • Acceptance of telemedicine
    • Time Frame: 1 month
    • Acceptance of telemedicine in consultations during the COVID-19 pandemic. To evaluate patients’ acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ) as a model. The resulting questionnaire has 10 questions.

Secondary Measures

  • Patient satisfaction
    • Time Frame: 1 month
    • Global satisfaction score on a scale from1 to 5 (1=lowest; 5=highest satisfaction)

Participating in This Clinical Trial

Inclusion Criteria

  • Patients contacted by telemedicine (phone and/or video call) during the COVID-19 pandemic in outpatient clinics – Follow-up of patients with any chronic disease and postoperative patients, preoperative and urgent consultation – Age greater than or equal to 18 years Exclusion Criteria:

  • Patients with cognitive or sensory difficulties or with insufficient comprehension of the language in which the survey is conducted – Patients who decline to take part in the telephone survey

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
  • Provider of Information About this Clinical Study
    • Principal Investigator: Luis Sánchez Guillen, Colorectal Surgeon Hospital General Universitario Elche – Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.